J. Tift Mann

8.1k total citations · 4 hit papers
21 papers, 6.0k citations indexed

About

J. Tift Mann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Tift Mann has authored 21 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Tift Mann's work include Coronary Interventions and Diagnostics (16 papers), Cerebrovascular and Carotid Artery Diseases (10 papers) and Cardiac Imaging and Diagnostics (7 papers). J. Tift Mann is often cited by papers focused on Coronary Interventions and Diagnostics (16 papers), Cerebrovascular and Carotid Artery Diseases (10 papers) and Cardiac Imaging and Diagnostics (7 papers). J. Tift Mann collaborates with scholars based in United States, Germany and Australia. J. Tift Mann's co-authors include Gregg W. Stone, Jeffrey J. Popma, Stephen G. Ellis, Charles O’Shaughnessy, Joel Greenberg, Mary E. Russell, Augustin DeLago, Steven R. Steinhubl, Edward T.A. Fry and Peter B. Berger and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

J. Tift Mann

21 papers receiving 5.8k citations

Hit Papers

Early and Sustained Dual Oral Antiplatelet Therapy Follow... 2002 2026 2010 2018 2002 2004 2005 2004 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Tift Mann United States 12 4.6k 4.4k 1.4k 1.3k 620 21 6.0k
Paul Barragan France 22 5.3k 1.2× 4.9k 1.1× 1.6k 1.1× 1.4k 1.1× 631 1.0× 69 6.8k
S. Schulz Germany 40 3.3k 0.7× 4.0k 0.9× 937 0.7× 882 0.7× 814 1.3× 109 5.1k
Anthony Gershlick United Kingdom 39 4.9k 1.1× 5.4k 1.2× 2.3k 1.7× 1.1k 0.9× 654 1.1× 164 7.2k
Érick Schampaert Canada 23 3.3k 0.7× 2.9k 0.7× 1.1k 0.8× 901 0.7× 298 0.5× 62 4.2k
Camino Bañuelos Spain 36 3.5k 0.8× 4.1k 0.9× 1.1k 0.8× 1.2k 0.9× 446 0.7× 116 5.1k
Rosana Hernández Spain 35 3.1k 0.7× 3.5k 0.8× 1.0k 0.7× 1.2k 0.9× 370 0.6× 101 4.5k
Massimiliano Fusaro Germany 36 4.2k 0.9× 3.3k 0.7× 1.3k 0.9× 1.9k 1.4× 481 0.8× 133 5.8k
Martin Hadamitzky Germany 40 4.2k 0.9× 4.7k 1.1× 3.9k 2.8× 1.1k 0.8× 511 0.8× 138 7.9k
Jean‐Marc Lablanche France 28 2.1k 0.4× 3.0k 0.7× 1.1k 0.8× 724 0.5× 458 0.7× 66 4.0k
William O. Suddath United States 42 5.5k 1.2× 5.4k 1.2× 2.4k 1.7× 1.8k 1.3× 424 0.7× 249 7.8k

Countries citing papers authored by J. Tift Mann

Since Specialization
Citations

This map shows the geographic impact of J. Tift Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tift Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tift Mann more than expected).

Fields of papers citing papers by J. Tift Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tift Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tift Mann. The network helps show where J. Tift Mann may publish in the future.

Co-authorship network of co-authors of J. Tift Mann

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tift Mann. A scholar is included among the top collaborators of J. Tift Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tift Mann. J. Tift Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gray, William A., Alan C. Yeung, Donald E. Cutlip, et al.. (2011). A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial. International Journal of Cardiology. 157(1). 96–101. 5 indexed citations
2.
Safian, Robert D., Michael R. Jaff, John F. Bresnahan, et al.. (2010). Protected Carotid Stenting in High‐Risk Patients: Results of the SpideRX Arm of the Carotid Revascularization with ev3 Arterial Technology Evolution Trial. Journal of Interventional Cardiology. 23(5). 491–498. 6 indexed citations
3.
Aoki, Jiro, Gary S. Mintz, Neil J. Weissman, et al.. (2008). Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 1(2). 161–167. 8 indexed citations
4.
Wood, Frances O., et al.. (2008). Unprotected left main disease managed with drug‐eluting stents: Long‐term outcome of 100 patients with increased surgical risk. Catheterization and Cardiovascular Interventions. 71(4). 533–538. 12 indexed citations
5.
Aoki, Jiro, Gary S. Mintz, Neil J. Weissman, et al.. (2008). Impact of Mild or Moderate Renal Insufficiency on the Intravascular Ultrasonic Analysis of Chronic Vascular Response to Paclitaxel-Eluting and Bare-Metal Stents (from the TAXUS IV, V, and VI Trials). The American Journal of Cardiology. 102(8). 1009–1016. 3 indexed citations
6.
Pinto, Duane S., Gregg W. Stone, Stephen G. Ellis, et al.. (2006). Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 48(1). 32–36. 112 indexed citations
7.
Weissman, Neil J., Joerg Koglin, David A. Cox, et al.. (2005). Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation. Journal of the American College of Cardiology. 45(8). 1201–1205. 72 indexed citations
8.
Ellis, Stephen G., Jeffrey J. Popma, John M. Lasala, et al.. (2005). Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Journal of the American College of Cardiology. 45(8). 1193–1200. 122 indexed citations
9.
Stone, Gregg W., Stephen G. Ellis, Louis Cannon, et al.. (2005). Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease. JAMA. 294(10). 1215–1215. 612 indexed citations breakdown →
10.
Dixon, Simon, J. Tift Mann, Michael A. Lauer, et al.. (2005). A Randomized, Controlled Trial of Saphenous Vein Graft Intervention with a Filter‐Based Distal Embolic Protection Device: TRAP Trial. Journal of Interventional Cardiology. 18(4). 233–241. 19 indexed citations
11.
Stone, Gregg W., Stephen G. Ellis, David A. Cox, et al.. (2004). A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease. New England Journal of Medicine. 350(3). 221–231. 2104 indexed citations breakdown →
12.
Popma, Jeffrey J., Stephen G. Ellis, David A. Cox, et al.. (2004). 843-3 Late quantitative angiographic results following treatment with a polymer-based paclitaxel-eluting stent compared with a bare metal stent in patients with de novo coronary disease: The TAXUS-IV angiographic results. Journal of the American College of Cardiology. 43(5). A87–A87. 2 indexed citations
13.
Stone, Gregg W., Stephen G. Ellis, Charles O’Shaughnessy, et al.. (2004). 843-4 Reduction in late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: Results from TAXUS-IV. Journal of the American College of Cardiology. 43(5). A87–A87. 3 indexed citations
14.
Stone, Gregg W., Stephen G. Ellis, David A. Cox, et al.. (2004). One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent. Circulation. 109(16). 1942–1947. 594 indexed citations breakdown →
15.
Steinhubl, Steven R., Peter B. Berger, J. Tift Mann, et al.. (2002). Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention. JAMA. 288(19). 2411–2411. 2213 indexed citations breakdown →
16.
Schwartz, Robert S., Yoshiki Kobayashi, Stephanie H. Wilson, et al.. (2001). Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. The American Journal of Cardiology. 88(3). 253–259. 46 indexed citations
17.
Teirstein, Paul S., J. Tift Mann, Eliot Schechter, et al.. (1999). Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. The American Journal of Cardiology. 83(12). 1623–1628. 6 indexed citations
18.
Burchenal, J.E.B., David S. Marks, J. Tift Mann, et al.. (1998). Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. The American Journal of Cardiology. 82(4). 511–515. 26 indexed citations
19.
Archie, J.P. & J. Tift Mann. (1989). Infected Femoral Arteriovenous Fistula After Percutaneous Insertion of an Intra-aortic Balloon. Southern Medical Journal. 82(6). 778–779. 1 indexed citations
20.
Mann, J. Tift, et al.. (1986). Correlation of cineangiographic and pathology findings in coronary artery disease.. PubMed. 41(4). 261–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026